Hap Trading, LLC Vaxart, Inc. Put Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$2.7 - $5.28 $17,550 - $34,320	-6,500 Reduced 37.57%	10,800 $43,000
Q1 2022 May 12, 2022	BUY	$4.29 - $6.64 $12,012 - $18,592	2,800 Added 19.31%	17,300 $46,000
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $13,270 - $18,308	-2,300 Reduced 13.69%	14,500 $31,000
Q3 2021 Nov 10, 2021	SELL	$6.67 - $9.8 $97,382 - $143,080	-14,600 Reduced 46.5%	16,800 $20,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $10.78 $158,884 - $338,492	31,400 New	31,400 $33,000
Q1 2021 May 14, 2021	SELL	$5.64 - $23.33 $146,076 - $604,247	-25,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $90,650 - $206,682	25,900 New	25,900 $96,000

108

37.9M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.